Concepedia

Bart Jessen

BJ

Statistics

Publications

31

Citations

1.7K

H-Index

19

Active since

1995

Affiliations

Pfizer (United States)(Current)

University of California, Davis

Covance (United States)

Veterinary Medical Teaching Hospital

Drug Safety Research Unit

Bart Jessen is an author at Pfizer (United States) specializing in medicine, cell biology, and pharmacology.

Top concepts

Publications per year

1995–2020

31

Publications

31

Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model

Shihao Chen, Li‐Fen Lee, Timothy S. Fisher et al. · Cancer Immunology Research · 2014 · 270 citations · Full text

Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells

Yvonne Will, James A. Dykens, Sashi Nadanaciva et al. · Toxicological Sciences · 2008 · 213 citations

, , +12

A high content screening assay for identifying lysosomotropic compounds

Sashi Nadanaciva, Shuyan Lu, David F. Gebhard et al. · Toxicology in Vitro · 2010 · 202 citations

, , +8

Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies

Wenyue Hu, Tae Sung, Bart Jessen et al. · Clinical Cancer Research · 2015 · 163 citations

Lysosomal adaptation: How cells respond to lysosomotropic compounds

Shuyan Lu, Tae Sung, Nianwei Lin et al. · PLoS ONE · 2017 · 154 citations · Full text

, , +17

1–5 of 31